Clearance Summary
Diafil & Diafil Capsule received FDA 510(k) clearance under submission number K210421, sponsored by DiaDent Group International. The device was reviewed via the Special premarket notification pathway and assigned to the Dental review panel. The statutory decision date of record is 2021-06-28.
- Submission: K210421
- Applicant / Sponsor: DiaDent Group International
- Clearance pathway: Special
- Review panel: Dental
- Device class: Class II
- Regulation citation: 21 CFR 872.3690
- Decision date: 2021-06-28
Classification & Regulation
This clearance is catalogued under FDA product code EBF and 21 CFR 872.3690, within the Dental review panel as a Class II device.